Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Lanz

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Molecular Autism|November 19, 2013
Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of actionThomas A Lanz, Edward Guilmette, Mark M Gosink, et al.
Molecular Therapy. Methods & Clinical Development|May 30, 2023
Comparing molecular and computational approaches for detecting viral integration of AAV gene therapy constructsElias M Oziolor, Steven W Kumpf, Jessie Qian, et al.
Molecular Therapy. Advances|May 15, 2026
DNA damage/p53, innate immune, and unfolded protein responses are activated in primate liver after toxic, high-dose AAV-SMN1 deliveryPedram Moeini, Martín Bilbao-Arribas, Elizabeth Guruceaga, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditionsHong-My Nguyen, Kristin E Alexander, Mark Collinge, et al.
Translational Psychiatry|February 20, 2021
Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signalingWei Chou Tseng, Veronica Reinhart, Thomas A Lanz, et al.
Translational Psychiatry|May 25, 2019
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorderThomas A Lanz, Veronica Reinhart, Mark J Sheehan, et al.
Biochemical Pharmacology|December 14, 2007
Peripheral elevation of IGF-1 fails to alter Abeta clearance in multiple in vivo modelsThomas A Lanz, Christopher T Salatto, Anthony R Semproni, et al.
Scientific Reports|January 19, 2026
A rat model of Immunologic and hypertensive kidney injurySeo-Kyoung Hwang, Jeffrey Morin, Christopher Houle, et al.
Journal of Immunotoxicology|February 13, 2025
Generation of cynomolgus monkey capsid-specific positive control cells for IFNγ ELISpot assays for adeno-associated gene therapy applicationsSandra Casinghino, Karrie Tartaro, Jessica Anderson, et al.
Journal of Neuroinflammation|May 16, 2018
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injuryJustin R Piro, Georgette L Suidan, Jie Quan, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Molecular Autism|November 19, 2013
Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of actionThomas A Lanz, Edward Guilmette, Mark M Gosink, et al.
Molecular Therapy. Methods & Clinical Development|May 30, 2023
Comparing molecular and computational approaches for detecting viral integration of AAV gene therapy constructsElias M Oziolor, Steven W Kumpf, Jessie Qian, et al.
Molecular Therapy. Advances|May 15, 2026
DNA damage/p53, innate immune, and unfolded protein responses are activated in primate liver after toxic, high-dose AAV-SMN1 deliveryPedram Moeini, Martín Bilbao-Arribas, Elizabeth Guruceaga, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditionsHong-My Nguyen, Kristin E Alexander, Mark Collinge, et al.
Translational Psychiatry|February 20, 2021
Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signalingWei Chou Tseng, Veronica Reinhart, Thomas A Lanz, et al.
Translational Psychiatry|May 25, 2019
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorderThomas A Lanz, Veronica Reinhart, Mark J Sheehan, et al.
Biochemical Pharmacology|December 14, 2007
Peripheral elevation of IGF-1 fails to alter Abeta clearance in multiple in vivo modelsThomas A Lanz, Christopher T Salatto, Anthony R Semproni, et al.
Scientific Reports|January 19, 2026
A rat model of Immunologic and hypertensive kidney injurySeo-Kyoung Hwang, Jeffrey Morin, Christopher Houle, et al.
Journal of Immunotoxicology|February 13, 2025
Generation of cynomolgus monkey capsid-specific positive control cells for IFNγ ELISpot assays for adeno-associated gene therapy applicationsSandra Casinghino, Karrie Tartaro, Jessica Anderson, et al.
Journal of Neuroinflammation|May 16, 2018
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injuryJustin R Piro, Georgette L Suidan, Jie Quan, et al.
Pageof 5